Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Effects of SCN1A and GABA receptor genetic polymorphisms on carbamazepine tolerability and efficacy in Chinese patients with partial seizures: 2-year longitudinal clinical follow-up.

Zhou BT, Zhou QH, Yin JY, Li GL, Qu J, Xu XJ, Liu D, Zhou HH, Liu ZQ.

CNS Neurosci Ther. 2012 Jul;18(7):566-72. doi: 10.1111/j.1755-5949.2012.00321.x. Epub 2012 May 17.

PMID:
22591328
2.

Comprehensive analysis of the association of SCN1A gene polymorphisms with the retention rate of carbamazepine following monotherapy for new-onset focal seizures in the Chinese Han population.

Zhou BT, Zhou QH, Yin JY, Li GL, Xu XJ, Qu J, Liu D, Zhou HH, Liu ZQ.

Clin Exp Pharmacol Physiol. 2012 Apr;39(4):379-84. doi: 10.1111/j.1440-1681.2012.05680.x.

PMID:
22292851
3.

Association between two functional SNPs of SCN1A gene and efficacy of carbamazepine monotherapy for focal seizures in Chinese Han epileptic patients.

Wang P, Zhou Q, Sheng Y, Tang B, Liu Z, Zhou B.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2014 May;39(5):433-41. doi: 10.3969/j.issn.1672-7347.2014.05.001.

4.

Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy.

Yun W, Zhang F, Hu C, Luo X, Xue P, Wang J, Ge Y, Meng H, Guo Y.

Epilepsy Res. 2013 Dec;107(3):231-7. doi: 10.1016/j.eplepsyres.2013.09.011. Epub 2013 Sep 30.

PMID:
24125961
5.
6.

Comparison of the retention rates between carbamazepine and valproate as an initial monotherapy in Chinese patients with partial seizures: A ten-year follow-up, observational study.

Hu Y, Huang Y, Quan F, Hu Y, Lu Y, Wang XF.

Seizure. 2011 Apr;20(3):208-13. doi: 10.1016/j.seizure.2010.11.020. Epub 2010 Dec 15.

7.

Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients.

Daci A, Beretta G, Vllasaliu D, Shala A, Govori V, Norata GD, Krasniqi S.

PLoS One. 2015 Nov 10;10(11):e0142408. doi: 10.1371/journal.pone.0142408. eCollection 2015.

8.

A functional polymorphism in the SCN1A gene does not influence antiepileptic drug responsiveness in Italian patients with focal epilepsy.

Manna I, Gambardella A, Bianchi A, Striano P, Tozzi R, Aguglia U, Beccaria F, Benna P, Campostrini R, Canevini MP, Condino F, Durisotti C, Elia M, Giallonardo AT, Iudice A, Labate A, La Neve A, Michelucci R, Muscas GC, Paravidino R, Zaccara G, Zucca C, Zara F, Perucca E.

Epilepsia. 2011 May;52(5):e40-4. doi: 10.1111/j.1528-1167.2011.03097.x.

10.

A common SCN1A splice-site polymorphism modifies the effect of carbamazepine on cortical excitability--a pharmacogenetic transcranial magnetic stimulation study.

Menzler K, Hermsen A, Balkenhol K, Duddek C, Bugiel H, Bauer S, Schorge S, Reif PS, Klein KM, Haag A, Oertel WH, Hamer HM, Knake S, Trucks H, Sander T, Rosenow F; EPICURE-Consortium.

Epilepsia. 2014 Feb;55(2):362-9. doi: 10.1111/epi.12515. Epub 2014 Jan 13.

11.

Effects of ABCB1 polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy.

Meng H, Guo G, Ren J, Zhou H, Ge Y, Guo Y.

Epilepsy Behav. 2011 May;21(1):27-30. doi: 10.1016/j.yebeh.2011.02.015. Epub 2011 Apr 13.

PMID:
21493161
12.

Response to carbamazepine in children with newly diagnosed partial onset epilepsy.

Holland KD, Glauser TA.

Neurology. 2007 Aug 7;69(6):596-9.

PMID:
17679679
13.

Association of SCN1A, SCN2A and ABCC2 gene polymorphisms with the response to antiepileptic drugs in Chinese Han patients with epilepsy.

Ma CL, Wu XY, Zheng J, Wu ZY, Hong Z, Zhong MK.

Pharmacogenomics. 2014 Jul;15(10):1323-36. doi: 10.2217/pgs.14.89.

PMID:
25155934
14.

Failure to detect association between polymorphisms of the sodium channel gene SCN1A and febrile seizures in Chinese patients with epilepsy.

Zhang C, Wong V, Ng PW, Lui CH, Sin NC, Wong KS, Baum L, Kwan P.

Epilepsia. 2010 Sep;51(9):1878-81. doi: 10.1111/j.1528-1167.2010.02587.x.

15.

SCN1A, SCN2A and SCN3A gene polymorphisms and responsiveness to antiepileptic drugs: a multicenter cohort study and meta-analysis.

Haerian BS, Baum L, Kwan P, Tan HJ, Raymond AA, Mohamed Z.

Pharmacogenomics. 2013 Jul;14(10):1153-66. doi: 10.2217/pgs.13.104.

PMID:
23859570
16.

SCN1AIVS5-91G>A polymorphism is associated with susceptibility to epilepsy but not with drug responsiveness.

Kumari R, Lakhan R, Kumar S, Garg RK, Misra UK, Kalita J, Mittal B.

Biochimie. 2013 Jun;95(6):1350-3. doi: 10.1016/j.biochi.2013.02.006. Epub 2013 Mar 1.

PMID:
23466530
17.
18.

A comparative study of vigabatrin vs. carbamazepine in monotherapy of newly diagnosed partial seizures in children.

Sobaniec W, Kułak W, Strzelecka J, Smigielska-Kuzia J, Boćkowski L.

Pharmacol Rep. 2005 Sep-Oct;57(5):646-53.

19.

Association between PK/PD-involved gene polymorphisms and carbamazepine-individualized therapy.

Ma CL, Jiao Z, Wu XY, Hong Z, Wu ZY, Zhong MK.

Pharmacogenomics. 2015;16(13):1499-512. doi: 10.2217/pgs.15.94. Epub 2015 Aug 28.

PMID:
26314341
20.

Supplemental Content

Support Center